2 insiders at Pulse Biosciences, Inc. (PLSE) reported open-market stock purchases totaling $26,590,676 in recent weeks, according to filings with the U.S. Securities and Exchange Commission. The largest reported purchase came from DUGGAN ROBERT W (director, 10 percent owner: ), who acquired 660,233 shares at $19.69 on May 11, 2026.
Source: SEC Form 4. Option grants and tax-withholding sales are excluded.
| Date | Insider | Role | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|
| 2026-05-11 | DUGGAN ROBERT W | director, 10 percent owner: | 660,233 | $19.69 | $12,999,988 | SEC Form 4 |
| 2026-05-11 | LAVIOLETTE PAUL A | director, officer: Chief Executive Officer | 15,000 | $19.69 | $295,350 | SEC Form 4 |
| 2026-05-11 | LAVIOLETTE PAUL A | director, officer: Chief Executive Officer | 15,000 | $19.69 | $295,350 | SEC Form 4 |
| 2026-05-11 | DUGGAN ROBERT W | director, 10 percent owner: | 660,233 | $19.69 | $12,999,988 | SEC Form 4 |
Pulse Biosciences, Inc. is a Healthcare company in the Medical - Instruments & Supplies industry. It carried a market capitalization of about $1.7B, with shares trading near $24.99.
This article is automated factual reporting of public SEC filings, for informational purposes only. It is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security, and reflects no opinion on the company. Figures are drawn from filings believed reliable but are not guaranteed. Always verify against the primary SEC filing and consult a licensed professional. Investing can lose value, up to total loss.